Theranostics

简称THERANOSTICS
新锐分类医学
JCR分类医学:研究与实验
ISSN1838-7640
EISSN1838-7640
出版商IVYSPRING INT PUBL
新锐分区1 区
2025 JIF14.9
JIF分区Q1

简介

《Theranostics》是Ivyspring International Publisher出版的治疗诊断学期刊,发表诊疗一体化各领域的高质量研究。期刊位列JCR Q1区和中科院1区Top,是诊疗一体化研究者的高水平发表平台。

最新文献

Discovery of a novel Nrf2 activator that modulates mitochondrial function in neurons by regulating DHRS3-Nrf2 interaction after ischemic stroke.

PMID: 419936112026-03-30

巨噬细胞膜仿生肉桂醛纳米药物通过抑制巨噬细胞M1极化改善炎症性肠病

PMID: 419936362026-03-25

肺菌群失调破坏FFAR2介导的抗肺炎克雷伯菌先天免疫回路

PMID: 419936262026-03-12

近红外光激活的利多卡因微针贴片用于快速局部麻醉

PMID: 419936272026-03-09

H3K18 lactylation-mediated SPHK1-SIRT1 feedback loop accelerates pyroptosis of tubular epithelial cells in sepsis-associated acute kidney injury.

PMID: 417992012026-02-18

利用邻近诱导偶联策略开发树突状细胞靶向疫苗

PMID: 417991862026-02-11

心肌细胞来源的OTUD7B通过去泛素化SERCA2a促进心脏肥大

PMID: 416954872026-02-04

Why 11β-HSD1 inhibitors show variable efficacy in Alzheimer's therapy: an APOE4-dependent HSD11B1 mechanism.

PMID: 416954902026-01-21

Flowerbed-inspired biomimetic 3D-printed scaffolds functionalized with urine-derived stem cell exosomes promote alveolar bone regeneration by regulating energy metabolism.

PMID: 416085752026-01-14

The novel B-cell epitope peptide vaccine, MAX449, exhibits significant anti-tumor efficacy and enhances the therapeutic effects of PD-1 antibodies on tumors by modulating the activity of PMN-MDSCs.

PMID: 416085652026-01-14

CK2-mediated HDAC5 shuttling regulates DNA end resection through Ku70 deacetylation.

PMID: 416085622026-01-08

T淋巴细胞膜仿生纳米药物与放疗协同增强Mg2+介导的肿瘤金属免疫治疗并预防复发

PMID: 416085702026-01-08

Ligand-directed oral lipidic nanoplatform enables sustained ferroptosis and immune reprogramming via multivalent transporter-mediated metronomic delivery.

PMID: 415101712026-01-01

Endothelial KSR2 regulated by genetic variation protects against atherosclerosis through AMPKα1 stabilization.

PMID: 414248492026-01-01

Systemic targeting of aberrant neovascular tufts using trehalose-dendrimer nanocarriers for the treatment of proliferative retinopathies.

PMID: 413559622026-01-01

Verteporfin-loaded hydrogel targeting YAP-mediated MDSCs recruitment for the treatment of residual tumors after incomplete radiofrequency ablation.

PMID: 414248632026-01-01

Polydopamine nanoparticles restore cognition via targeted dopamine delivery and septo-hippocampal cholinergic activation.

PMID: 416085872026-01-01

Splicing factor FUS facilitates the progression of PIT1-lineage PitNETs by upregulating MDM2.

PMID: 415101732026-01-01

A novel whole cancer cell vaccine based on modified β-glucan elicits robust anti-tumor immunity.

PMID: 415101492026-01-01

Fibroblast-derived NEU1 as a therapeutic target for improving cortical bone integrity and fracture healing.

PMID: 413561972026-01-01